Skip to content

Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01252121
Enrollment
27
Registered
2010-12-02
Start date
2010-10-31
Completion date
2011-06-30
Last updated
2012-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Keywords

Dry Eye, Ocular Retention Time

Brief summary

The purpose of this study is to evaluate the ocular retention time of Systane Ultra compared to Hialid and saline.

Interventions

One drop in study eye, one time, during office visit.

OTHERHialid 0.1 Artificial Tears Eye Drops

One drop in study eye, one time, during office visit.

One drop in study eye, one time, during office visit.

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with mild to moderate dry eye as defined in the protocol. * Able and willing to follow instructions. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Any medical condition that may affect the results of the study. * History or evidence of ocular or intraocular surgery within the past six months. * History of intolerance or hypersensitivity to any component of the study medications. * Use of concomitant topical ocular medications during the study period. * Ocular conditions that may preclude safe administration of the test article. * Unwilling to discontinue contact lens wear during the study period. * Participation in an investigational drug or device study within 30 days of enrollment. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Ocular surface residence timeTime to eventOcular surface residence time is defined as the time for fluorescence intensity to return to baseline value after a drop of ophthalmic dye is instilled in the study eye. Dye retention will be measured with a fluorophotometer.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026